|
Market Cap (10-Jun) $67,259,416 (1,589th) |
Close (30-Jun) $0.072 |
Volume (30-Jun) 290,277 |
Shortsold (26-May) 418,619 (0.18%) (406th) |
|
52w High $0.63 |
52w Low $0.200 |
P/E - |
EPS 0 |
BIO released this announcement to the ASX on 14 February 2022, 8:33. The announcement is marked as price sensitive, and is 8 page(s) in length and 423.41kb in size.
You can view all announcements from BIO and see how they appear on a price chart on the announcements page.
At the date of this announcement, BIO was 0.013% short sold according to ASIC data. It was ranked the 577th most shorted stock on the ASX. It is now ranked as the 406th most shorted stock on the ASX with 0.184% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from BIO | |
|---|---|
| Biome secures $1.2 million revolving debt facility | 28 June 2023, 8:35 |
| Biome surpasses $7m sales revenue target | 15 June 2023, 8:31 |
| Correction to Quarterly Activities Report | 20 April 2023, 10:07 |
| Supplementary announcement Acne clinical trial | 14 February 2022, 8:33 |
| Successful acne clinical trial result with product to launch | 9 February 2022, 9:58 |
| Clinical trial on asthma sufferers validates Biome probiotic | 2 February 2022, 9:17 |
| Notification of cessation of securities - BIO | 1 February 2022, 13:21 |
You must be logged in to post a reply.
